IP Library › Granted Patent US 11,851,516
Granted Patent B2
US 11,851,516 · App. 17/045,032 · Granted Dec 26, 2023

Phosphorylcholine group-containing polysiloxane monomer

Inventors: Yosuke Matsuoka (Kawasaki, JP); Akane Katori (Kawasaki, JP); Norio Iwakiri (Kawasaki, JP); Shu Takashima (Kawasaki, JP); Ryuya Gotanda (Kawasaki, JP); Nobuyuki Sakamoto (Kawasaki, JP)
Assignee: NOF CORPORATION
C08F290/068C08F290/148C08G77/20C08G77/30C08G77/395G02C7/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,851,516
App. No.
17/045,032
Granted
Dec 26, 2023
Kind
B2
Abstract

Provided is a monomer suitable for application to an ophthalmic device, the monomer showing high surface hydrophilicity, a high oxygen transmissibility, and appropriate mechanical strength when copolymerized with a polymerizable monomer, such as a hydrophilic monomer. It has been recognized that a phosphorylcholine group-containing polysiloxane monomer can solve the problems.

Claims (17)

1. A phosphorylcholine group-containing polysiloxane monomer, which is represented by the formula (1):

where “a” represents an integer of from 20 to 500, “b” represents an integer of from 1 to 70, “c” represents 0 or 1, “p” and “q” each represent 0 or 1, and X represents —CH 2 — or —CH 2 CH 2 —.

2. A method of producing a phosphorylcholine group-containing polysiloxane monomer represented by the formula (1), the method comprising a step of subjecting a hydrosilyl group-containing di-methacrylate-terminated silicone represented by the formula (4) and an allyl group-containing phosphorylcholine compound represented by the formula (5) to an addition reaction:

where “a” represents an integer of from 20 to 500, “b” represents an integer of from 1 to 70, “c” represents 0 or 1, “p” and “q” each represent 0 or 1, and X represents —CH 2 — or —CH 2 CH 2 —;

where “a” represents an integer of from 20 to 500, “b” represents an integer of from 1 to 70, and “p” and “q” each represent 0 or 1;

where “c” represents 0 or 1, and Z represents CH 2 ═CHCH 2 — or CH 2 ═CH—.

3. A monomer composition, comprising:

10 parts by weight to 60 parts by weight of a phosphorylcholine group-containing polysiloxane monomer represented by the formula (1); and

40 parts by weight to 90 parts by weight of one kind or a plurality of kinds of hydrophilic monomers:

where “a” represents an integer of from 20 to 500, “b” represents an integer of from 1 to 70, “c” represents 0 or 1, “p” and “q” each represent 0 or 1, and X represents —CH 2 — or —CH 2 CH 2 —.

4. The monomer composition according to claim 3 , wherein the hydrophilic monomers are any one or more selected from the group consisting of 2-hydroxyethyl (meth)acrylate, N-vinylpyrrolidone, N,N-dimethylacrylamide, 2-(methacryloyloxyethyl)-2-(trimethylammonioethyl) phosphate, methyl methacrylate, and hydroxypropyl (meth)acrylate.

5. A polymer, which is obtained by polymerizing the monomer composition of claim 3 .

6. A polymer, which is obtained by polymerizing the monomer composition of claim 4 .

7. The composition according to claim 1 , wherein the composition is a composition for an ophthalmic device.

8. The composition according to claim 3 , wherein the composition is a composition for an ophthalmic device.

9. An ophthalmic device, comprising the polymer of claim 4 .

10. An ophthalmic device, comprising the polymer of claim 5 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: MATSUOKA, YOSUKE; KATORI, AKANE; IWAKIRI, NORIO; TAKASHIMA, SHU; GOTANDA, RYUYA; SAKAMOTO, NOBUYUKI
To: NOF CORPORATION
Reel/Frame 055583/0817 →
Priority Claims (1)
JP 2018-073052 · Apr 5, 2018 · national
Continuity (1)
Related Publication 20210189044A1 · Jun 24, 2021